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Fentanyl is a potent, short-acting narcotic analgesic widely used as surgical anaesthetic. This article 
presents a case in which fentanyl was self-injected by a 41-year old nurse, an employee at the hospital 
emergency department, who was found dead at home. She had no known history of drug and alcohol 
abuse. Two syringes, one empty and one filled with a clear liquid, were found near the body, while a needle 
was stuck into her hand.
Toxicological analysis showed fentanyl poisoning. Fentanyl overdose was declared the cause of death and 
the manner of death was classified as suicide.
To our knowledge, death due to the intravenous injection of fentanyl has not previously been reported in 
Croatia.
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Fentanyl, N-[1-(2-phenylethyl)-4-piperidinyl]-
N-phenyl-propanamide (Figure 1), is a narcotic 
analgesic, which primarily binds to opioid µ-receptors, 
producing not only the analgesia for which it is 
primarily used but also sedation, euphoria, and at 
high doses, respiratory depression and death (1). It 
was introduced into medical practice in the 1960s as 
an intravenous anaesthetic under the trade name of 
Sublimaze (2). Fentanyl has an LD50 of 3.1 mg kg
-1 in 
rats, and 0.03 mg kg-1 in monkeys.
Fentanyl overdose is classically associated 
with intravenous use of α-methylfentanyl and 3-
methylfentanyl, a powder form that is chemically 
different from therapeutic fentanyl (3). Occasionally 
these fentanyl derivates are sold as heroin and at other 
times they go by street monikers such as synthetic
heroin and China white, which is the same term used 
for high-quality south-east Asian heroin (4). However, 
fentanyl overdose has also been reported in cases of 
excessive transdermal application and ingestion or 
inhalation of transdermal patches (5-8).
The transdermal fentanyl system is designed to 
deliver a specific dose at a constant rate based on 
the initial concentration present in the patch. This 
delivery system effectively limits the peak versus 
trough concentration, which is a common problem 
associated with other routes of administration. We 
present a case in which a fatal dose of fentanyl was 
injected.
Figure 1 Fentanyl structural formula
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MATERIALS AND METHODS
Multiple samples were collected and stored at 4 °C 
until analysis in order to establish drug distribution. 
Samples were screened for ethanol, common drugs 
of abuse and other basic drugs. Quantification 
and confirmation analyses were performed by 
first isolating fentanyl by extraction of 1 mL g-1 to 
5 mL g-1 specimen. Solid-phase extraction was 
performed using Amberlite XAD-2, polyaromatic 
adsorbent resin (Supelco; SIGMA ALDRICH, 
Taufkirchen, Germany) (9, 10).
Underivatised specimens were analysed using a 
Shimadzu GC-2010 mass spectrometer with ion trap 
(mass selective detector, MSD). The chromatographic 
column was RTX-5MS (5 % diphenyl - 95 % dimethyl 
polysiloxane, 30 m, and 0.25 mm i.d, with a film thick 
0.25 µm). The initial column temperature of 90 °C 
was held for 3 min, then programmed to 270 °C at 
20 °C min-1, and held for 25 min. Ultra-pure grade 
helium was used as the carrier gas at a flow rate of 
about 1.5 mL min-1. Quantification was performed 
using selective ion mode (SIM) with external standard 
curve prepared with fentanyl citrate 0.0785 mg mL-1
(eq. to fentanyl 0.05 mg mL-1). For fentanyl three ions 
were monitored m/z: 245, 146 and 189.
Blood-alcohol concentration (BAC) was measured 
using the Shimadzu GC-2010 with headspace and 
flame ionization detector (FID). Ter-Butanol was used 
as standard solution.
Case report
A 41-year old woman, employed as a nurse at the 
hospital emergency department, was found dead at 
home. She had a family, was well-situated, and had 
no psychological problems and previous suicidal 
attempts. She had no known history of drug and 
alcohol abuse. Two syringes, one empty and one filled 
with a clear liquid, were found near the body, while a 
needle was stuck into her hand.
Macroscopic and microscopic findings were 
unspecific and did not point to a certain precise cause 
of death.
Toxicological analysis showed fentanyl poisoning 
(Figure 2). Blood concentration of fentanyl was 
540 µg L-1; in stomach tissue mixed with blood it was 
40 µg g-1 and in urine 95 µg g-1. Alcohol in blood and 
urine samples was not detected. The syringes and the 
needle found at the scene were positive for fentanyl. 
No other organic bases were detected, including 
other drugs of abuse such as opioids, cannabinoids, 
amphetamines, cocaine or hallucinogens.
Figure 2 Selected ion chromatogram (A) and characteristic spectra of fentanyl (B)
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The toxicological results and circumstantial 
evidences of the case indicate that the death resulted 
primarily from fentanyl overdose and the manner of 
death was classified as suicide.
DISCUSSION
To our knowledge, death due to intravenous 
injection of fentanyl has not yet been reported in 
Croatia. Developed by Janssen Pharmaceutica, 
fentanyl was originally introduced in the United 
States in 1968 for use as an intravenous analgesic-
anaesthetic. Exposure may occur through the 
parenteral, oral, transmucosal, and dermal routes. 
Classical abuse of fentanyl has involved health care 
professionals who had access to the controlled 
drug. Since their introduction in 1990, transdermal 
fentanyl patches have been abused in a number of 
ways. Fentanyl is a potent analgesic. Intravenous or 
intramuscular fentanyl is used in the management 
of acute or post-surgical pain, as a component of 
balanced anaesthesia, or as preoperative analgesic 
in a hospital. As intravenous fentanyl is not readily 
available even in hospitals, it has lower poisoning 
incidence than transdermal fentanyl patches which 
are used for the treatment of chronic pain (4). Oral 
transmucosal fentanyl is used for acute pain in patients 
concurrently receiving transdermal therapy. Fentanyl 
and its derivates have high dependence liability, and 
rapidly metabolise in the liver. About 70 % of a dose 
is excreted in the urine in 72 h, mostly as metabolites. 
The estimated minimum lethal dose is 2 mg (4).
Edinboro et al. reported a case of an 83-year-old 
female with terminal cancer who was found with 
a fatal level of fentanyl in her blood (25 g L-1) after 
applying three patches to her chest (5). Arvanitis and 
Satonik described a case of a 38-year-old man who 
was found unresponsive on three separate occasions 
after chewing transdermal fentanyl patches (6). Tharp 
et al. presented four cases in which the source of 
fentanyl were transdermal patches, from which it 
was extracted and then applied intravenously. In all 
these cases, the victims were white males who died at 
home (11). In all cases, fentanyl patches and needles 
with syringes were found at the scene, and there was 
physical evidence of intravenous injection on the body 
at the time of autopsy. It is very important to analyse 
all objects found at the crime scene. In our case, 
the results obtained from the syringes with needles 
instigated all other analyses.
Anderson and Muto analysed 25 deaths after 
transdermal fentanyl application (1). When fentanyl 
was not considered to be the cause of death, heart 
blood and liver tissue concentrations ranged from 
<2.7 ng mL-1 to 7 ng mL-1 (mean 3.6 ng mL-1)
and from 5.8 ng g-1 to 31 ng g-1 (mean 14.6 ng
g-1), respectively. When fentanyl was considered to 
be the cause of death, heart blood and liver tissue 
concentrations ranged from 16 ng mL-1 to 139 ng
mL-1 (mean 50 ng mL-1) and from 69 ng g-1 to 
352 ng g-1 (mean 167 ng g-1), respectively. The authors 
concluded that, in the case of transdermally delivered 
fentanyl, blood and liver tissue concentrations above 
7 ng mL-1 and 69 ng g-1, respectively, may indicate a 
fentanyl overdose. In our case, blood, stomach tissue 
mixed with blood and urine concentrations ranged 
from 40 ng mL-1 to 540 ng mL-1 (Table 1).
Although with pharmacological action similar to 
opiates, fentanyl has much different chemical structure 
and is not detected by standard narcotic screening 
tests. In the cases presented, it is highly improbable 
that intravenous abuse of fentanyl extracted from 
transdermal patches would have been considered or 
detected without thorough investigation of the scene 
and the decedent’s history.
REFERENCES
1. Anderson DT, Muto JJ. Duragesic transdermal patch: 
postmortem tissue distribution of fentanyl in 25 cases. 
J Anal Toxicol 2000;24:627-34.
2. Answers.com [displayed 30 May 2007]. Available at 
http://www.answers.com/topic/fentanyl
Table 1 Fentanyl and its distribution in tissues
Sample Fentanyl/µg L-1
Stomach tissue mixed with blood 40
Blood 540
Urine 95
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Fentanil je sna`an narkotik u velikoj mjeri upotrebljavan kao anestetik pri kirur{kim zahvatima. U ovom radu 
prikazan je slu~aj samoubojstva upotrebom fentanila. 41-godi{nja medicinska sestra, zaposlena u hitnoj 
slu`bi prona|ena je mrtva u svom stanu. Nije bilo podataka o njezinu za`ivotnom u`ivanju alkohola niti 
drugih sredstava ovisnosti. Dvije {price, jedna prazna i druga ispunjena prozirnom teku}inom, prona|ene 
su kraj njezina tijela, dok je igla bila ubodena u njezinu ruku. Toksikolo{ka analiza dala je pozitivan rezultat 
na fentanil. Uzrok smrti bio je predoziranje fentanilom u svrhu samoubojstva.
Prema na{im saznanjima, ovo je prvi dokazani slu~aj samoubojstva u Hrvatskoj koji je po~injen 
fentanilom.
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